IndraLab

Statements

P5091 activates Parkinson Disease. 1 / 1

| 1

reach

"In conclusion, compared with P5091 and RMPs‐R4F alone, P5091@RMPs‐R4F demonstrates an effective therapeutic effect on BRM.As PD‐1 antibody therapy has shown potential to treat lung metastases, and we found that P5091 treatment could enhance PD‐L1 expression, 22 we hypothesized that P5091@RMPs‐R4F combined with PD‐1 antibody therapy could achieve greater efficacy."

36698296

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

P5091 activates Parkinson Disease. 1 / 1

INDRA sources:

Databases

Reading